As filed with the Securities and Exchange Commission on May 20, 2005.

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K
 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)

May 20, 2005 (May 19, 2005)

 


 

MEDAREX, INC.

(Exact name of registrant as specified in its charter)

 


 

New Jersey

 

0-19312

 

22-2822175

(State of other jurisdiction
of incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

707 State Road, Princeton, N.J. 08540-1437

(Address of Principal Executive Offices)

 

Registrant’s telephone number, including area code: (609) 430-2880

 

Not Applicable

(Former name or former address, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).

o            Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 

MEDAREX, INC.

TABLE OF CONTENTS

FOR

CURRENT REPORT ON FORM 8-K

 

Item 1.01

 

Entry into a Material Agreement

 

 

 

 

 

Item 5.02

 

Election of Director

 

 

 

 

 

Item 9.01

 

Financial Statements and Exhibits.

 

 

 

 

 

Signature

 

 

 

 

2



 

Item 1.01.                                         Entry into a Material Agreement.

 

            On May 19, 2005, the shareholders of Medarex, Inc. approved the 2005 Equity Incentive Plan, a copy of which is incorporated by reference into this Current Report on Form 8-K.

 

Item 5.02.                                         Election of Directors.

 

            On May 19, 2005, the shareholders of Medarex, Inc. elected Dr. Patricia M. Danzon and Mr. Michael A. Appelbaum to serve as directors for three-year terms ending at the 2008 annual meeting of shareholders.  Additional information on Mr. Appelbaum and Dr. Danzon is set forth in the Medarex Proxy Statement filed with the Securities and Exchange Commission on April 8, 2005.

 

Item 9.01                                            Financial Statements and Exhibits.

 

(c)                                  Exhibits.  The following material is filed as an exhibit to this Current Report on Form 8-K:

 

Exhibit
Number

 

 

 

 

 

99.1

 

Medarex, Inc. 2005 Equity Incentive Plan, incorporated by reference to Appendix B to Medarex, Inc.’s Proxy Statement filed with the SEC on April 8, 2005. (File No. 000-19312).

 

3



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

MEDAREX, INC.

 

 

Registrant

 

 

 

 

 

 

Date: May 20, 2005

 

 

By:

/s/ Christian S. Schade

 

 

 

 

Christian S. Schade

 

 

 

Senior Vice President and

 

 

 

Chief Financial Officer

 

4



 

EXHIBIT INDEX

 

Exhibit
Number

 

Description

 

 

 

 

 

 

 

99.1

 

Medarex, Inc. 2005 Equity Incentive Plan, incorporated by reference to Appendix B to Medarex, Inc.’s Proxy Statement filed with the SEC on April 8, 2005. (File No. 000-19312).

 

 

 

5